Arrowgrass Capital Partners (US)’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-500
Closed -$4.36M 591
2017
Q2
$4.36M Sell
500
-2,077
-81% -$176K 0.03% 400
2017
Q1
$22.9M Buy
2,577
+1,799
+231% +$150K 0.24% 113
2016
Q4
$5.76M Buy
778
+441
+131% +$33K 0.07% 245
2016
Q3
$2.55M Sell
337
-125
-27% -$9.57K 0.03% 280
2016
Q2
$3.56M Buy
+462
New +$36.5K 0.04% 227
2015
Q4
Sell
-85
Closed -$658K 427
2015
Q3
$658K Buy
+85
New +$7.53K 0.01% 381

Other funds holding HCA

Arrowgrass Capital Partners (US)'s HCA Position: Q2 2017 in Review

Arrowgrass Capital Partners (US) sold out of HCA Healthcare (HCA) in Q2 2017, closing a stake of 47,891 shares — an estimated $4.05M sold.

Arrowgrass Capital Partners (US) first reported a position in HCA in Q4 2013 and held it in 6 quarters. The position peaked at $9.91M in Q4 2013. 570 funds tracked by Wall St. Rank hold HCA as of Q2 2017.

  • Arrowgrass Capital Partners (US) reported no remaining HCA Healthcare position as of Q2 2017 after selling out during the quarter.
  • Arrowgrass Capital Partners (US) sold 47,891 HCA Healthcare shares in Q2 2017, an estimated $4.05M.
  • Arrowgrass Capital Partners (US) first reported a position in HCA Healthcare in Q4 2013 and held it in 6 quarters.
  • Arrowgrass Capital Partners (US)'s HCA Healthcare position peaked at $9.91M in Q4 2013.
  • 570 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2017.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q2 2017, filed 14 Aug 2017.